Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
UBS
Queensland Health
McKinsey
Johnson and Johnson
Cantor Fitzgerald
Covington
US Department of Justice
Novartis
McKesson

Generated: August 20, 2017

DrugPatentWatch Database Preview

ALKERAN Drug Profile

« Back to Dashboard

Which patents cover Alkeran, and when can generic versions of Alkeran launch?

Alkeran is a drug marketed by Apotex Inc and is included in two NDAs.

The generic ingredient in ALKERAN is melphalan. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the melphalan profile page.

Summary for Tradename: ALKERAN

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list41
Clinical Trials: see list135
Patent Applications: see list9,760
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ALKERAN at DailyMed

Pharmacology for Tradename: ALKERAN

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
ALKERAN
melphalan hydrochloride
INJECTABLE;INJECTION020207-001Nov 18, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Apotex Inc
ALKERAN
melphalan
TABLET;ORAL014691-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ALKERAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apotex Inc
ALKERAN
melphalan hydrochloride
INJECTABLE;INJECTION020207-001Nov 18, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Cantor Fitzgerald
Citi
Moodys
Cerilliant
Queensland Health
Teva
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot